MIT and Caltech researchers have developed a new type of fMRI sensor that can measure a specific neurotransmitter (dopamine) — a more detailed, higher-resolution indicator of neural activity than conventional fMRI, which measures blood flow in the brain.

Dopamine holds particular interest for neuroscientists because of its role in motivation, reward, addiction and several neurodegenerative conditions, including Parkinson’s disease.